
Jonathan Corren MD
Asthma & Allergic Conditions, Clinical & Laboratory Immunology
Allergy Medical Clinic
Join to view full profile
10780 Santa Monica BlvdSuite 280Los Angeles, CA 90025
Phone+1 310-312-5050
Fax+1 310-575-9292
Dr. Corren is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Colorado School of Medicine/National Jewish Health (Adult)Fellowship, Allergy and Immunology, 1988 - 1990
University of California Davis HealthResidency, Internal Medicine, 1985 - 1987
University of Southern California/Los Angeles General Medical Center (USC/LA General)Internship, Internal Medicine, 1983 - 1984
University of California San Diego School of MedicineClass of 1983
Certifications & Licensure
CA State Medical License 1984 - 2028
CO State Medical License 1990 - 1993
American Board of Allergy and Immunology Allergy & Immunology
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Top Doctors:LA Area Castle Connolly, 2013
- Top Doctors:Southern California Castle Connolly, 2012
- Super Doctor SuperDoctors.com
Clinical Trials
Publications & Presentations
PubMed
- Impact of Sex on Prediction of Asthma Attacks by Clinical Risk Factors and Type 2 Biomarkers.Sebastian Riemann, Fleur L Meulmeester, Samuel Mailhot-Larouche, Sanjay Ramakrishnan, Michael E Wechsler
Chest. 2026-06-01 - 3 citationsFRONTIER-3: a randomised phase 2a study to investigate tozorakimab, an anti-interleukin-33 monoclonal antibody, in early-onset asthma.Jonathan Corren, Fred Reid, Rachel Moate, Eulalia Jimenez, Muhammad Waqas Sadiq
ERJ Open Research. 2026-01-01 - 17 citationsTezepelumab for the treatment of chronic spontaneous urticaria: Results of the phase 2b INCEPTION study.Julie McLaren, Yun Chon, Kevin S Gorski, Jonathan A Bernstein, Jonathan Corren
The Journal of Allergy and Clinical Immunology. 2025-06-01
Journal Articles
- Editorial How Important Is Adherence to Inhaled Medications Before Starting a Biologic Therapy for Asthma?Jonathan Corren, MD, ScienceDirect
Press Mentions
Add Tezepelumab to SCIT to Improve Cat Allergy Symptoms?November 21st, 2022
Add Tezepelumab to SCIT to Improve Cat Allergy Symptoms?November 18th, 2022
Fight Cat Allergies with Newest Asthma Drug?October 13th, 2022
Professional Memberships
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









